PCRX R&D Expense Growth
Pacira Biosciences Inc · R&D Expense Growth
PCRX R&D Expense Growth
Latest reported43.81%period ending
PCRX FY R&D Growth (YoY) (0.00% → 43.81%)
Latest values, visible window
High-resolution chart · PNG
PCRX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 43.8052% | |
| 6.9764% | |
| -10.0711% | |
| 52.6636% | |
| -6.5229% | |
| -17.607% | |
| 29.5055% | |
| -2.7963% | |
| 25.4214% | |
| 59.3678% | |
| 53.0191% | |
| -13.1215% | |
| 116.9669% | |
| -33.1877% | |
| -20.1578% | |
| -28.9902% | |
| -21.0182% | |
| 0% |